Suchergebnisse - "Liao, Xuelian"

PubPharm (102)

41

The Prognostic Nutritional Index is associated with mortality of COVID-19 patients in Wuhan, China

enthalten in: Journal of clinical laboratory analysis | 2020

von Wang, R. | He, M. | Yin, W. | +10

42

Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19 : A multicenter, observational study

enthalten in: The American journal of emergency medicine | 2020

von Yang, J. | Liao, X. | Yin, W. | +8

43

Bone and bone marrow involvement in neuroblastoma : A case report

enthalten in: Medicine | 2020

von Huang, C. | Jiang, S. | Liao, X. | +3

44

Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models

enthalten in: Oncoimmunology | 2020

von Qin, D. | Li, D. | Zhang, B. | +6

45

Intermedin promotes vessel fusion by inducing VE-cadherin accumulation at potential fusion sites and to achieve a dynamic balance between VE-cadherin-complex dissociation/reconstitution

enthalten in: MedComm | 2020

von Kong, L. | Xiao, F. | Wang, L. | +10

46

Therapeutic potential of targeting MYCN : A case series report of neuroblastoma with MYCN amplification

enthalten in: Medicine | 2020

von Huang, C. | Jiang, S. | Yang, J. | +3

47

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

enthalten in: Critical care (London, England) | 2020

von Ma, A. | Cheng, J. | Yang, J. | +3

CommentIn: Crit Care. 2020 Aug 28;24(1):532. - PMID 32859254

48

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

enthalten in: Critical care | 2020

von Ma, A. | Cheng, J. | Yang, J. | +3

49

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

enthalten in: Critical care | 2020

von Ma, A. | Cheng, J. | Yang, J. | +3

50

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations

enthalten in: Signal transduction and targeted therapy | 2020

von Liu, N. | Yu, M. | Yin, T. | +7